Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지

Long-term Results of Radiotherapy for Subfoveal Choroidal Neovascularization (CNV) in Age-related Macular Degeneration (ARMD)

연령관련 황반하 맥락막 신생혈관증에서 방사선의 장기적 치료 결과

  • Kim, Bo-Kyong (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Kim, Il-Han (Department of Radiation Oncology, Seoul National University College of Medicine)
  • 김보경 (서울대학교 의과대학 방사선종양학교실) ;
  • 김일한 (서울대학교 의과대학 방사선종양학교실)
  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

[ $\underline{Purpose}$ ]: We performed this prospective randomized study to evaluate the efficacy and the complications of radiotherapy for Subfoveal CNV in ARMD and to compare the treatment results at two dosages (14.4 Gy and 19.8 Gy). $\underline{Materials\;and\;Methods}$: 60 eyes of 55 patients were enrolled, and randomized into 14.4 Gy (31 eyes) or 19.8 Gy (29 eyes) groups. CT was used to plan the radiotherapy. All patients received radiotherapy with a 1.8 Gy daily dose using 4 MV photon. We categorized treatment results as improved, stable, or deteriorated based on visual acuity changes of more than 2 lines on the ETDRS chart. $\underline{Results}$: Median follow-up period was 33.5 months. At 12 months, visual acuity improved in 9 (16.7%), stable in 41 (75.9%), and aggravated in 4 (7.4%) of 54 evaluated eyes. At 24 months, 49 eyes (81.7%) were evaluated. Visual acuity improved in 6 (12.2%), was stable in 33 (67.4%), and deteriorated in 10 (20.4%). At 36 months, 37 eyes were evaluated. Six (16.2%) eyes were improved, 21 (56.8%) stable, and 10 (27.0%) deteriorated. No significant difference in response was observed between the 14.4 Gy and 19.8 Gy groups (Mantel-Haenszel $x^2=0.4756$). The proportion of eyes with a vision of $20/100{\leq}increased$ from 28.3% initially to 32.7% after 24 months of radiotherapy. There were no severe acute or chronic complications. $\underline{Conclusion}$: External beam radiotherapy with doses of 14.4 or 19.8 Gy may be an effective treatment for subfoveal CNV in ARMD. No dose-response relationships with respect to treatment response or toxicity were observed between the 14.4 Gy and 19.8 Gy groups.

목 적: 본 연구는 연령관련 황반변성 중 황반하 맥락막 신생혈관증에서 외부방사선치료의 효과 및 부작용의 확인 및 조사선량과의 관련성을 확인하기 위하여 시행되었다. 대상 및 방법: 55명의 환자에서 60안이 본 연구에 포함되었으며, 14.4 Gy군(31안)과 19.8 Gy군(29안)으로 무작위 배정되었다. 방사선치료는 CT를 이용하여 계획하였으며, 4 MV 광자선을 이용하여 1일 1.8 Gy를 조사하였다. 치료의 효과는 ETDRS 시력표에서 3줄 이상의 변화를 보일 경우 향상, 안정, 악화로 판정하였다. 결 과: 중간 추적관찰기간은 33.5개월이었다. 방사선치료 종료 12개월 후, 54안이 추적관찰 가능하였으며, 이 중 9안(16.7%)이 향상, 41안(75.9%)이 안정, 4안(7.4%)이 악화되었다. 24개월 및 36개월 후에는 각각 49안, 37안이 추적관찰 가능하였으며, 24개월에는 6안(12.2%)이 향상, 33안(67.4%)이 안정, 10안(20.4%)이 악화되었으며, 36개월에는 6안(16.2%)이 향상, 21안(56.8%)이 안정, 10안(27%)이 악화되었다. 두 선량 군간에 효과는 의미 있는 차이를 보이지 않았다(Mantel-Haenszel $x^2=0.4756$). 20/100 이상의 시력을 지닌 환자의 비율은 방사선치료 전 28.3%에서 치료 24개월 후 32.7%로 증가하였다. 방사선치료와 연관된 심각한 급성 또는 만성합병증은 관찰되지 않았다. 결 론: 14.4 또는 19.8 Gy의 외부방사선조사는 연령관련 황반변성 중 황반하 맥락막 신생혈관증에 효과적인 치료법일 가능성을 지니며, 치료의 효과 및 부작용 면에서 두 선량 간에 의미 있는 차이는 관찰되지 않았다.

Keywords

References

  1. Staar S, Krott R, Mueller RP, et al. External beam radiotherapy for subretinal neovascularizalion in age-relaled macular degeneralion: in this treatment efficient? Int J Radiat Oncol Biol Phys 1999;45:467-473 https://doi.org/10.1016/S0360-3016(99)00186-8
  2. Freund KB, Yannuzzi LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularization. Am J Opthalmol 1993;115:786-791 https://doi.org/10.1016/S0002-9394(14)73649-9
  3. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of randomized clinical trial. Arch Ophthalmol 1991;109:1220-1231 https://doi.org/10.1001/archopht.1991.01080090044025
  4. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Arch Opthalmol 1994;112:480-488 https://doi.org/10.1001/archopht.1994.01090160056023
  5. Macular Photocoagulation Study Group. Persistent and recurrent neovasularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Arch Ophthalmol 1994; 112:489-499 https://doi.org/10.1001/archopht.1994.01090160065024
  6. Parikh S, Nori D. Radiation therapy to prevent stenosis of peripheral vascular accesses. Semin Radiat Oncol 1999;9:144-154 https://doi.org/10.1016/S1053-4296(99)80004-6
  7. Sebag-Montefiore DJ, Doughty D, Biggs D, et al. Stereotactic multiple arc radiotherapy. I. Vascular malformations of the brain: an analysis of the first 108 patients. Br J Neurosurg 1995;9:441-452 https://doi.org/10.1080/02688699550041070
  8. Matsuhashi H, Takahashi D, Noda Y, et al. Low-dose radiation therapy for choroidal neovascularization in age-related macular degeneration. Nippon Ganka Gankkai Zasshi 1996;100: 803-809
  9. Chakravarthy U, Huston RF, Archer DB. Treatment of age- related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Opthalmol 1993;77:265-273 https://doi.org/10.1136/bjo.77.5.265
  10. Bergink GJ, Deutman AF, van den Broek JF, et al. Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study. Graefes Arc Clin Exp Opthalmol 1994;232:591-598 https://doi.org/10.1007/BF00193119
  11. Freier J, Longton WA, Miyamoto CT, et al. External radiotherapy in macular degeneration: technique and preliminary subjective responses. Int J Radiat Oncol Biol Phys 1996;36: 857-860 https://doi.org/10.1016/S0360-3016(96)00428-2
  12. Brady LW, Freire JE, Longton WA, et al. Radiation therapy for macular degeneration: technical considerations and preliminary results. Int J Radiat Oncol Biol Phys 1997;39:945-948 https://doi.org/10.1016/S0360-3016(97)00708-6
  13. Berson AM, Finger PT, Sherr DL, et al. Radiotherapy for age-related macular degeneration: preliminary results of a potentially new treatment. Int J Radiat Oncol Biol Phys 1996;36: 861-865 https://doi.org/10.1016/S0360-3016(96)00338-0
  14. Donati G, Soubrane D, Quaranta M, et al. Radiotherapy for isolated occult subfoveal neovascularization in age related macular degeneration: a pilot study. Br J Opthalmol 1999;83: 646-651 https://doi.org/10.1136/bjo.83.6.646
  15. Bergink GJ, Hoyng CB, van der Maazen RW, et al. A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age related macula degeneration: radiation versus observation. Graefes Arch Clin Exp Ophthalmol 1998;236:321-325 https://doi.org/10.1007/s004170050085
  16. Tholen AM, Meister A, Bernasconi pp, et al. Radiotherapy for choroidal neo-vascularization (CNV) in age-related macular degeneration (ARM D). Klin Monatsbl Augenheilkd 2000;216:112-115 https://doi.org/10.1055/s-2000-10528
  17. Spaide RF, Guyer DR, McCormick B, et al. External beam radiation therapy for choroidal neovascularization. Opthalmology 1998;105:24-30 https://doi.org/10.1016/S0161-6420(98)90980-0
  18. Holz FG, Engenhart-Gabillic R, Unnebrink K, et al. A prospective, randomized, double masked trial on radiation therapy for neovascular age-related macular degeneration (RAD study). Opthalmology 1999;106:2239-2247 https://doi.org/10.1016/S0161-6420(99)90522-5
  19. Gripp S, Stammen J, Peterson C, et al. Radiotherapy in age-related macula degeneration. Int J Radiat Oncol Biol Phys 2002:52:489-495 https://doi.org/10.1016/S0360-3016(01)02611-6
  20. Mandai M, Takahashi M, Miyamoto H, et al. Long-term outcome after radiation therapy for subfoveal choroidal neovascularization associated with age-related macular degeneration. Jpn J Opthalmol 2000;44:530-537 https://doi.org/10.1016/S0021-5155(00)00217-3